These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2899840)

  • 1. The effect of diltiazem on mortality and reinfarction after myocardial infarction.
    Multicenter Diltiazem Postinfarction Trial Research Group
    N Engl J Med; 1988 Aug; 319(7):385-92. PubMed ID: 2899840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Moss AJ; Oakes D; Rubison M; McDermott M; Carleen E; Eberly S; Brown M
    Am J Cardiol; 1991 Aug; 68(5):429-33. PubMed ID: 1872266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between diltiazem and left ventricular function after myocardial infarction. Multicenter Diltiazem Post-Infarction Research Group.
    Moss AJ; Oakes D; Benhorin J; Carleen E
    Circulation; 1989 Dec; 80(6 Suppl):IV102-6. PubMed ID: 2688978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.
    Boden WE; Krone RJ; Kleiger RE; Oakes D; Greenberg H; Dwyer EJ; Miller JP; Abrams J; Coromilas J; Goldstein R
    Am J Cardiol; 1991 Feb; 67(5):335-42. PubMed ID: 1994656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of nonfatal myocardial reinfarction. Multicenter Diltiazem Postinfarction Trial Research Group.
    Benhorin J; Moss AJ; Oakes D
    J Am Coll Cardiol; 1990 Feb; 15(2):253-8. PubMed ID: 2299062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study.
    Gibson RS; Young PM; Boden WE; Schechtman K; Roberts R
    Am J Cardiol; 1987 Aug; 60(4):203-9. PubMed ID: 3303886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.
    Wong SC; Greenberg H; Hager WD; Dwyer EM
    J Am Coll Cardiol; 1992 Jun; 19(7):1421-5. PubMed ID: 1593034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of reinfarction subsequent to non-Q-wave infarction.
    Roberts R; Gibson RS
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S36-46. PubMed ID: 2468975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.
    Goldstein RE; Boccuzzi SJ; Cruess D; Nattel S
    Circulation; 1991 Jan; 83(1):52-60. PubMed ID: 1984898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
    Pfeffer MA; Braunvald Iu; Moĭe LA; Basta L; Braun EDzh ; Kaddi TE; Dévis BR; Geltman EM; Goldman S; Fleĭker GS
    Kardiologiia; 1993; 33(12):14-23, 3. PubMed ID: 7910865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
    Zijlstra F; Hoorntje JC; de Boer MJ; Reiffers S; Miedema K; Ottervanger JP; van 't Hof AW; Suryapranata H
    N Engl J Med; 1999 Nov; 341(19):1413-9. PubMed ID: 10547403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
    N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
    Yusuf S; Mehta SR; Xie C; Ahmed RJ; Xavier D; Pais P; Zhu J; Liu L;
    JAMA; 2005 Jan; 293(4):427-35. PubMed ID: 15671427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial).
    Marcus FI; Friday K; McCans J; Moon T; Hahn E; Cobb L; Edwards J; Kuller L
    Am J Cardiol; 1990 Mar; 65(9):559-66. PubMed ID: 2178380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.